GI
SLDB icon

GAMMA Investing’s Solid Biosciences SLDB Stock Holding History

GAMMA Investing’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2K Buy
1,417
+300
+27% +$2.27K ﹤0.01% 3029
2026
Q1 		$8.04K Buy
1,117
+875
+362% +$5.62K ﹤0.01% 3179
2025
Q4 		$1.36K Buy
242
+146
+152% +$791 ﹤0.01% 3711
2025
Q3 		$592 Buy
+96
New +$561 ﹤0.01% 3693
2025
Q2 		– Sell
-153
Closed -$566 – 3882
2025
Q1 		$566 Buy
153
+39
+34% +$167 ﹤0.01% 3662
2024
Q4 		$456 Buy
114
+91
+396% +$500 ﹤0.01% 3586
2024
Q3 		$160 Buy
+23
New +$187 ﹤0.01% 3531

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GAMMA Investing's SLDB Position: Q2 2026 in Review

GAMMA Investing increased its Solid Biosciences (SLDB) stake by 27% in Q2 2026, buying an estimated $2.27K and bringing the position to 1,417 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.

GAMMA Investing first reported a position in SLDB in Q3 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • GAMMA Investing held 1,417 shares of Solid Biosciences worth $14.2K as of Q2 2026.
  • GAMMA Investing bought 300 Solid Biosciences shares in Q2 2026, an estimated $2.27K.
  • Solid Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3029 holding.
  • GAMMA Investing first reported a position in Solid Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.